UCSF

Tagged: Research

Desai named the director of new UCSF bioengineering initiative

The Health Innovation Via Engineering (HIVE) program is designed to inspire collaborations in bioengineering research.

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

USP/UCSF fellowship to support research in the quality and safety of medical products

A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.

Creating an inexhaustible database for drug molecules

School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.

Tamraz is featured PGRN Investigator

Bani Tamraz, PharmD, PhD, is the featured Pharmacogenomics Research Network Investigator (PGRN) for February 2019. An article on the group’s website describes his overall goal to build a patient-oriented program of pharmacogenetics research, teaching, and clinical practice that utilizes genetics...

QBI fellowship fosters curiosity and perseverance for women scientists

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about...

CRISPR-based obesity treatment shows promise for other diseases

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Combination drug therapy overcomes drug-resistant lung cancer in the lab

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

QBI scientists decipher how Ebola, dengue, and Zika infect human cells

In a pair of recent studies, scientists at the Quantitative Biosciences Institute uncovered how Ebola, dengue, and Zika hijack human proteins to infect human cells, findings that point to new approaches for treating these diseases.

Pages